Clinical Trial Update: Intramyocardial Delivery of Autologous Bone Marrow [Phase 2]

View source ↗

Summary

This clinical trial update notes that the Phase 2 intramyocardial delivery of autologous bone marrow for refractory angina has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Refractory Angina | Phase 2 | Status: SUSPENDED